Cargando…
A line immunoassay utilizing recombinant nucleocapsid proteins for detection of antibodies to human coronaviruses
Most coronaviruses infecting humans cause mild diseases, whereas severe acute respiratory syndrome (SARS)-associated coronavirus is an extremely dangerous pathogen. Here, we report the development of a serologic assay for detection of antibodies to human coronaviruses (HCoVs) based on recombinant nu...
Autores principales: | Lehmann, Christian, Wolf, Hans, Xu, Jianguo, Zhao, Quanbi, Shao, Yiming, Motz, Manfred, Lindner, Petra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127592/ https://www.ncbi.nlm.nih.gov/pubmed/18191362 http://dx.doi.org/10.1016/j.diagmicrobio.2007.12.002 |
Ejemplares similares
-
A recombinant nucleocapsid protein-based indirect enzyme-linked immunosorbent
assay to detect antibodies against porcine deltacoronavirus
por: SU, Mingjun, et al.
Publicado: (2015) -
Comparing Immunoassays for SARS-CoV-2 Antibody Detection in Patients with and without Laboratory-Confirmed SARS-CoV-2 Infection
por: Leuzinger, Karoline, et al.
Publicado: (2021) -
Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-19
por: Flinck, Heini, et al.
Publicado: (2021) -
Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays
por: Wolff, Fleur, et al.
Publicado: (2020) -
Targeting intra-viral conserved nucleocapsid (N) proteins as novel vaccines against SARS-CoVs
por: Thura, Min, et al.
Publicado: (2021)